K, M., A, S., K, M., M, S., E, T., P, S., . . . RJ, W. (2021). Nanohydroxyapatite (nHAp) Doped with Iron Oxide Nanoparticles (IO), miR-21 and miR-124 Under Magnetic Field Conditions Modulates Osteoblast Viability, Reduces Inflammation and Inhibits the Growth of Osteoclast – A Novel Concept for Osteoporosis Treatment: Part 1. Dove Medical Press.
Cita Chicago Style (17a ed.)K, Marycz, Smieszek A, Marcinkowska K, Sikora M, Turlej E, Sobierajska P, Patej A, Bienko A, y Wiglusz RJ. Nanohydroxyapatite (nHAp) Doped with Iron Oxide Nanoparticles (IO), MiR-21 and MiR-124 Under Magnetic Field Conditions Modulates Osteoblast Viability, Reduces Inflammation and Inhibits the Growth of Osteoclast – A Novel Concept for Osteoporosis Treatment: Part 1. Dove Medical Press, 2021.
Cita MLA (8a ed.)K, Marycz, et al. Nanohydroxyapatite (nHAp) Doped with Iron Oxide Nanoparticles (IO), MiR-21 and MiR-124 Under Magnetic Field Conditions Modulates Osteoblast Viability, Reduces Inflammation and Inhibits the Growth of Osteoclast – A Novel Concept for Osteoporosis Treatment: Part 1. Dove Medical Press, 2021.